Andreas Stelzl

Andreas Stelzl is a Senior Project Manager in Formulation Development at Coriolis Pharma since June 2020, specializing in drug product development of high concentrated liquid protein formulations for late-phase biopharmaceutical products, including monoclonal and bispecific antibodies. Prior roles at Coriolis Pharma include Project Manager and Scientist, where Andreas ensured operational success for multiple projects valued up to 3 M€ and 1 M€, respectively. Academic qualifications include a Master of Science in Pharmaceutical Sciences and a Master of Science in Pharmacy from Ludwig-Maximilians-Universität München and Cardiff University, along with a Bachelor of Science in Pharmaceutical Sciences. Additionally, Andreas completed a PhD at LMU München in collaboration with Bayer AG, focusing on high concentration liquid formulations for monoclonal antibodies.